Construction and evaluation of wild and mutant ofatumumab scFvs against the human CD20 antigen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Construction and evaluation of wild and mutant ofatumumab scFvs against the human CD20 antigen

Published:2022-05-17 Issue:3 Volume:53 Page:239-246
ISSN:1082-6068
Container-title:Preparative Biochemistry & Biotechnology
language:en
Short-container-title:Preparative Biochemistry & Biotechnology

Author:

Maleki Reza¹,Rahimpour Azam²,Rajabibazl Masoumeh¹^ORCID

Affiliation:

1. Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

General Medicine,Biochemistry,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10826068.2022.2073598

Reference35 articles.

1. The role of ofatumumab in the treatment of chronic lymphocytic leukemia resistant to previous therapies

2. The Biology of CD20 and Its Potential as a Target for mAb Therapy

3. Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties

4. Mechanisms of killing by anti-CD20 monoclonal antibodies

5. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced production and single step purification of biologically active recombinant anti-IL6 scFv from Escherichia coli inclusion bodies;Process Biochemistry;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP